CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
Control Cannula - Prosoft Cannula - Unicorn Cannula +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04512781
NCT04512781N/ACompleted
CompareCT.gov

Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Cannulae Designs

Vapotherm, Inc.·interventional·Posted Aug 14, 2020·Updated Feb 23, 2024

In Brief

A clinical study evaluating Control Cannula - Prosoft Cannula - Unicorn Cannula and Control Cannula - Unicorn Cannula - Prosoft Cannula for Dyspnea and 2 related conditions. Completed, enrolled 26 participants across 2 sites.

Detailed Summary

This study will evaluate the ability of High Velocity Nasal Insufflation \[HVNI\] next generation nasal cannula designs to effect ventilation and related physiological responses relative to the conventional legacy cannula design.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDyspnea, Hypercapnia, Respiratory Insufficiency
CountriesUnited States
CollaboratorsVA Pittsburgh Healthcare System, Erlanger Baroness Hospital

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedAug 14, 2020
Enrollment StartOct 1, 2020
Primary CompletionJun 7, 2022
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 5.9 years ago

Interventions

Control Cannula - Prosoft Cannula - Unicorn Cannuladevice

The purpose of this intervention is to evaluate the efficacy of a conventional legacy cannula design to provide targeted relief of dyspnea. The purpose of this intervention is to evaluate the efficacy of a next generation cannula to provide relief of dyspnea.

Control Cannula - Unicorn Cannula - Prosoft Cannuladevice

The purpose of this intervention is to evaluate the efficacy of a conventional legacy cannula design to provide targeted relief of dyspnea. The purpose of this intervention is to evaluate the efficacy of a next generation cannula to provide relief of dyspnea.